Epidemiological picture of tuberculosis in India is complex with wide
variation in the annual risk of infection and prevalence of disease. T
he concentration of the disease among younger age groups makes tubercu
losis a major socio-economic burden in India. The disability adjusted
life years (DALYS) is estimated to be around 63 and 46 lakhs of years
of life lost in men and women respectively. The burden is likely to in
crease with HIV epidemic with an increase of cases with dual infection
, increase in morbidity and mortality due to tuberculosis. Management
of drug resistant tuberculosis is a major hurdle in tuberculosis contr
ol and is a major step in cutting the chain of transmission to those w
ith HIV infection, AIDS and Immunodeficiency. Development of new thera
peutic modalities to address this problem are also urgently required.
Poor patient compliance has been the reason for failure of many contro
l programmes. Operational research studies conducted by the TRC have r
esulted in elucidation of socio-behavioural aspects of patients which
need further investigation for remedial measures. Studies to improve d
rug delivery and to measure the impact of health education and mass me
dia on compliance are areas which need to be concentrated. Newer techn
iques such a's DNA fingerprinting need to employed to improve knowledg
e of the patterns of transmission in communities. The impact of HIV in
fection on tuberculosis and the role of chemoprophylaxis in HIV infect
ed individuals in high risk populations, children in close contact wit
h newly diagnosed patients and HIV infected individuals need to be urg
ently explored. Improved methods for diagnosis of Mycobacterium tuberc
ulosis infection must await considerable advance in the understanding
of basic immunology, mycobacterial antigenic structure and host-parasi
tic interaction.